← Leaderboards
Gerald L Denardo
University Of California Davis
$3,030,924
Attributed
$3,030,924
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2005–06$5M$3.8M$2.5M$1.3M$0
'05
'06
Funding mix
By agency
NIH$13,004,439 · 3
By mechanism
P01$13,004,439 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California Davis
Same institution · by research overlap
- Claude F. Meares$5,274,336
- Sally J Denardo$2,893,757
- John M Boone$15,619,124
- Carol M. Richman$180,509
- Sui Shen$180,509
Others in their field
Top investigators on “Neoplasm /Cancer Radioimmunotherapy”
- Theodore G Krontiris · City Of Hope/Beckman Research Institute$5,350,711
- Jason A Koutcher · Sloan-Kettering Institute For Cancer Res$3,541,139
- Rosalyn D Blumenthal · Ctr For Molecular Medicine/Immunology$3,420,927
- Michael Rod Zalutsky · Duke University$3,254,012
- Edward A Neuwelt · Oregon Health And Science University$3,152,742
- Robert M Sharkey · Ctr For Molecular Medicine/Immunology$3,112,943
Research focus
Neoplasm /Cancer RadioimmunotherapyImmunoconjugatesTherapy Design /DevelopmentImmunologic Substance Development /PreparationStatistics /BiometryData ManagementBiomedical FacilityNeoplasm /Cancer Radionuclide TherapyNeoplasm /Cancer ImmunotherapyRadiopharmacologyCombination Cancer TherapyModel Design /DevelopmentAthymic MouseAntibodyMonoclonal AntibodyNonhodgkin'S LymphomaBiotechnologySurface Plasmon ResonanceComputer SimulationChemical SynthesisChelating AgentsBinding SitesNuclear Magnetic Resonance SpectroscopyPharmacokinetics
Grant awards (15)
Translational Multimodality " Antibody" Therapy$2,262,864
P01 · FY2006 · CA · contact PI
HLA-DR Targeted Synthetic High Affinity Ligands$519,709
P01 · FY2006 · CA · contact PI
Core--Biostatistics$491,075
P01 · FY2006 · CA · contact PI
Translational Multimodality " Antibody" Therapy$2,232,495
P01 · FY2005 · CA
HLA-DR Targeted Synthetic High Affinity Ligands$511,880
P01 · FY2005 · CA
Core--Biostatistics$453,224
P01 · FY2005 · CA
Translational Multimodality " Antibody" Therapy$2,069,586
P01 · FY2004 · CA
HLA-DR Targeted Synthetic High Affinity Ligands$452,489
P01 · FY2004 · CA
Core--Biostatistics$422,038
P01 · FY2004 · CA
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY$420,273
P01 · FY2002 · CA
Core--Biostatistics and data management$0
P01 · FY2002 · CA
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY$1,490,732
P01 · FY2001 · CA
Core--Biostatistics and data management$0
P01 · FY2001 · CA
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY$1,497,565
P01 · FY2000 · CA
Core--Biostatistics and data management$180,509
P01 · FY2000 · CA